You are viewing the site in preview mode
Skip to main content
| |
No apparent CAD (n = 4)
|
Non-obstructive CAD (n = 3)
|
Obstructive CAD (n = 7)
|
p value
|
|---|
|
Age (years)
|
51.8 ± 10.9
|
54 ± 13.5
|
51.9 ± 10.8
|
0.958
|
|
Male, n (%)
|
1 (25)
|
3 (100)
|
7 (100)
|
0.008*
|
|
Race- Malay, n (%)
|
4 (100)
|
3 (100)
|
7 (100)
|
–
|
|
Hypertension, n (%)
|
2 (50)
|
3 (100)
|
6 (86)
|
0.227
|
|
Hyperlipidemia, n (%)
|
2 (50)
|
2 (67)
|
6 (86)
|
0.442
|
|
Diabetes mellitus, n (%)
|
4 (100)
|
2 (67)
|
4 (57)
|
0.311
|
|
Smoking, n (%)
|
1 (25)
|
0 (0)
|
2 (29)
|
0.171
|
|
Atorvastatin, n (%)
|
4 (100)
|
3 (100)
|
6 (86)
|
0.584
|
|
Ezetimibe, n (%)
|
0 (0)
|
1 (33)
|
4 (57)
|
0.163
|
|
Ejection fraction (EF) (%)
|
51.98 ± 18.94
|
63.63 ± 14.60
|
47.50 ± 19.87
|
0.496
|
|
Total cholesterol (mg/dL)
|
3.66 ± 1.30
|
5.24 ± 0.66
|
5.40 ± 1.14
|
0.098
|
|
Triglycerides (mg/dL)
|
0.98 (0.31)
|
1.17 (0.00)
|
1.46 (1.19)
|
0.060
|
|
LDL cholesterol (mg/dL)
|
2.16 ± 1.04
|
3.09 ± 0.80
|
3.41 ± 0.87
|
0.172
|
|
HDL cholesterol (mg/dL)
|
1.06 ± 0.54
|
1.05 ± 0.13
|
1.28 ± 0.14
|
0.552
|
|
Fasting blood glucose (mmol/L)
|
7.90 ± 2.51
|
7.00 ± 3.08
|
7.26 ± 1.84
|
0.859
|
|
Serum creatinine (μmol/L)
|
76.50 ± 16.18
|
109.00 ± 29.61
|
95.57 ± 12.67
|
0.092
|
- Data are expressed as mean ± SD or median (IQR) for continuous variables and n (%) for categorical variables. *p < 0.05 indicates significant differences of baseline clinical or biochemical characteristics in 3 groups of CAD patients
